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aBstraCt
Age-related macular degeneration (AMD) is one of the leading causes of blindness in developed countries. It is esti-
mated that about 196 million people worldwide suffer from AMD. So far, despite many studies, no causative treat-
ment that can be used large scale has been discovered. In order to slow down, the progression of the disease, a change 
of the modifiable risk factors such as diet and prophylaxis in the form of nutritional supplements are recommended. 
The purpose of this work is to present types of supplementation and draw attention to the proper diet containing 
products rich in substances such as lutein and zeaxanthin protecting the eye against the rapid progression of dry 
AMD. 
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introduCtion
Age-related macular degeneration (AMD) is one 
of the leading causes of non-reversible visual impair-
ment in humans over 50 years old and frequently 
increases in those after 65 years of age [1]. The 
prevalence of AMD is about 196 million people 
worldwide [2, 3]. The disease affects the central 
part of retina called macula lutea and results in loss 
of central and sharp vision which is required for 
daily living activities as reading, driving and watch-
ing television.
Age-related macular degeneration can be clas-
sified as non-exudative (dry) or exudative (wet). 
Whereas wet AMD can be treated using anty-VEGF 
injections with a good clinical result, for the dry 
form of the disease there is no causative treatment 
[2, 4, 5]. Thus, the question appears — is it possible 
to prevent AMD and/or slow down its progression?
The pathogenesis of the disease is multifactorial 
and not fully understood but many publications 
point out the significant role of oxidative stress (OS) 
[6, 7]. In the course of AMD, the loss of retinal 
pigment epithelium (RPE) cells and photoreceptors 
in the macula area is observed. The retinal examina-
tion reveals the presence of drusen — extracellular 
deposits, which are located between Bruch’s mem-
brane and RPE. RPE cells have a high metabolic 
rate and therefore have the ability to produce reac-
tive oxygen species (ROS). What’s more, they are 
exposed to ROS through iron ion accumulation, 
exposure to high light and smoking. The pigment 
epithelium consisting of two carotenoids, which are 
lutein and zeaxanthin [two stereoisomers: (3R,3’R)-
zeaxanthin, and (3R,3’S)-zeaxanthin (meso-zeaxan-
thin)], is a natural protective barrier for the retina of 
the human eye from OS [7]. This discovery became 
the basis for the use of substances with antioxidant 
properties such as carotenoids (lutein, zeaxanthin), 
vitamin C and E and zinc in the prevention and 
treatment of this disease. 
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There are several modifiable and non-modifia-
ble risk factors connected with the progression of 
AMD. The most important are sex, age, genetic, 
diet, smoking, sunlight exposure, obesity and hy-
pertension [8, 9]. In this paper, we would like to 
emphasize the protective role of diet in the disease 
progression. 
A review of the latest and most frequently cited 
literature was carried out. We searched for the arti-
cles which focus on the relationship between nutri-
tional factors and AMD progression. They included 
works related to the diet in age-related macular 
degeneration and the latest information on AMD 
treatment methods. 
Scientific research in the field of biochemistry 
was also cited, in which the level of dietary compo-
nents in the supportive treatment of AMD was de-
termined.
the role of supplementation  
in amd
One of the most significant multicentral clinical 
trials that evaluate the role of antioxidants supple-
mentation on the rate of AMD progression were 
The Age-Related Eye Disease Study (AREDS) and 
The Age-Related Eye Disease Study 2 (AREDS2).
The Age-Related Eye Disease Study involved 
4757 patients, aged 55 to 80 years, presenting of ex-
tensive small drusen, intermediate or large drusen, 
noncentral geographic atrophy, or pigment abnor-
malities in one or both eyes, or advanced AMD or 
vision loss due to AMD in one eye. Patients were 
randomly assigned to one of four groups depending 
on the type of oral supplementation (Tab. 1): 
 — antioxidants (vitamin C — 500 mg; vitamin E 
— 400 IU; and b-carotene — 15 mg); 
 — zinc — 80 mg (as zinc oxide) and copper 
— 2 mg (as cupric oxide);
 — antioxidants plus zinc; 
 — placebo [10]. 
The study revealed that patients receiving zinc, 
antioxidants, or the combination of both showed 
a decrease in the rate of progression to advanced 
AMD. It was estimated that those receiving both 
zinc and antioxidants achieved a 25% reduction of 
progression to advanced AMD relative to placebo. 
The decreased percentage in visual acuity scores 
from 29% for those assigned to placebo to 23% for 
those assigned to antioxidants plus zinc. Moreover, 
the AREDS showed a statistically significant as-
sociation between the incidence of AMD and risk 
factors such as smoking, BMI, race, education, and 
age [11].
Due to the significant progress in the study of 
the effect of supplementation on AMD develop-
ment, soon after the publication of the results of 
AREDS in 2001, it was necessary to start further 
research in this direction, that was AREDS2 [11]. 
Modification of supplementation was also caused 
by reports of an increased risk of lung cancer in 
smokers after using b-carotene as well as urogenital 
infections resulting from taking zinc [12, 13].
In addition, the natural occurrence of lutein 
and zeaxanthin in the pigment epithelium was the 
basis for using these substances in further stud-
ies on AMD supplementation. The aim of the 
AREDS2 was to show whether adding lutein + ze-
axanthin, omega-3 long-chain polyunsaturated fatty 
acids [docosahexaenoic acid (DHA) + eicosapentae-
noic acid (EPA)], or both to the AREDS formula-
tion reduces the risk of developing advanced AMD. 
It is worth mentioning that DHA is an important 
structural component of the retina, and EPA may 
play the role of a precursor to signalling molecules 
that can affect retinal function, which was the basis 
for studying these nutrients. The second aim of 
the research was to evaluate the effect of eliminat-
ing b-carotene, lowering zinc doses, or both in the 
AREDS formulation [14]. The conclusion of the 
AREDS2 was that comparing to placebo, the addi-
tion of lutein/zeaxanthin and/or omega-3 fatty acids 
to the previous AREDS formulation had no sig-
nificant effect on AMD progression of visual acuity 
loss. Moreover, the results showed no effect of b-car-
otene elimination or lower-dose zinc on progression 
to advanced AMD. However, because of potential 
increased incidence of lung cancer in former smok-
ers, lutein + zeaxanthin could be an appropriate 
carotenoid substitute in the AREDS formulation. 
Addition of lutein and zeaxanthin may have some 
table 1. Commercially available formulas based 
on the age-related eye disease study — areds/areds2
nutrient areds formula areds2 formula
Vitamin C 400 mg 500 mg
Vitamin E 400 IU 400 IU
b-carotene 15 mg –
Lutein – 10 mg
Zeaxanthin – 2 mg
Zinc 80 mg 80 mg
Copper 2 mg 2 mg
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effect on AMD progression in those populations in 
which the dietary intake of these nutrients is low.
Over the years, many studies have been conduct-
ed to assess the effect of antioxidants supplementa-
tion on AMD. Feng et al. based on a meta-analysis 
of nine randomized trials (a total of 920 eyes) have 
shown that lutein supplementation at a dose of 
10 or 20 mg daily for more than 6 months can 
contribute to an increase in macular pigment opti-
cal density (MPOD), improvement of visual acuity 
and a better sense of contrast in patients with AMD 
[15]. Macular pigment levels, usually measured in 
terms of MPOD, may correspond with normal reti-
nal function [15–20].
The role of omega-3 fatty acids supplementation 
in AMD is also worth mentioning. They have the 
ability to renew in RPE cells, their deficiency can 
lead to degradation of photoreceptors as well as 
the accumulation of lipid filled drusen in RPE and 
sub-RPE space [21]. A number of studies have been 
conducted to assess the effects of omega-3 supple-
mentation on the development and progression of 
AMD. The Eye Disease Case-Control Study showed 
that the higher intake of n-3 fatty acids may be 
associated with the lower risk of AMD among pa-
tients with the lower linoleic acid (omega-6 fatty 
acid) consumption [22, 23]. The Nutritional AMD 
Treatment 2 (NAT2) study showed that higher EPA 
and DHA content in red blood cell membranes may 
have protective effects against AMD [24]. Some 
authors suggest that high doses of EPA (3.4 g) and 
DHA (1.6 g) daily for six months can result in im-
proved visual acuity in patients with dry AMD [25]. 
On the other hand, a 2015 Cochrane meta-analysis 
report that there is no evidence confirming that sup-
plementation with Omega-3 fatty acids prevents or 
slows the progression of AMD [26]. 
To sum up, although some scientific studies in-
dicate a positive effect of omega-3 fatty acid supple-
mentation in preventing the progression of AMD, it 
should be emphasized that most studies are observa-
tional and not supported by randomized controlled 
studies [21, 26]. Therefore, it seems appropriate 
to recommend that patients eat fatty fish or ome-
ga-3 fatty acid supplements as potentially beneficial 
in reducing the progression of AMD while inform-
ing patients that most of the data is based on obser-
vational studies [26].
Noteworthy is also another substance — resvera-
trol, which is a plant polyphenolic compound com-
monly found in peel and grape seeds as well as in red 
and white wine [27]. Resveratrol has antioxidant, 
anti-angiogenic and anti-inflammatory properties, 
which are used not only in the prevention of eye 
diseases but also in the prevention of cardiovas-
cular, cancer and neurodegenerative diseases [28]. 
Based on the literature, it is known that resveratrol 
acts on various types of eye cells by increasing the 
level of natural enzymes and the ability to molecu-
larly defend antioxidants. This substance, by limit-
ing pro-inflammatory factors such as interleukins 
and prostaglandins, as well as reducing chemical 
attraction and recruitment of immune cells to the 
inflammatory site, has anti-inflammatory capabili-
ties. In addition, resveratrol has been shown to have 
anti-VEGF activity and inhibits vascular endothe-
lial cell proliferation and migration. Resveratrol has 
been shown to be successfully used in many oph-
thalmic diseases based on animal models and in vivo 
experiments [28].
One of the more interesting and recent studies 
on the effects of resveratrol on RPE cells is the study 
by Nashine et al. The study evaluated the effects 
of over-the-counter nutrient supplements contain-
ing resveratrol and HPLC-purified resveratrol, in 
human transmitochondrial age-related macular de-
generation (AMD) retinal pigment epithelial (RPE) 
patient cell lines. These cell lines were obtained from 
dry and wet AMD patients. It turned out that res-
veratrol treatment with different resveratrol formu-
lations improved cell viability and decreased reactive 
oxygen species generation in each AMD patient 
cell line. Although further studies are required to 
establish the cytoprotective potential of resveratrol 
under different physiological conditions, this novel 
study established the positive effects of resveratrol 
supplements in macular degeneration patient cell 
lines in vitro [27]. The study used a maximum 
concentration of 1000 µM resveratrol as this dose 
was confirmed to be effective in previous studies 
that evaluated a wide range of resveratrol doses in 
AMD RPE [27]. 
diet in amd
When discussing the role of dietary supplements 
in the context of AMD, it should be emphasized 
that any supplementation can replace a proper, 
well-balanced diet. Therefore, it is important to 
determine which nutritional ingredients and in 
what proportions may have a beneficial effect in 
the prevention of AMD and patients with already 
diagnosed disease. Many studies have tried to deter-
mine the dietary patterns recommended in AMD 
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but it still seems difficult to develop general guide-
lines based on them [29–31]. Koning-Backus et 
al. investigated whether general dietary guidelines 
for healthy lifestyles are associated with a reduced 
risk of AMD. The study analyzed recommended 
minimum intake values for various food categories 
and standards, based on publicly available dietary 
recommendations from national food centers op-
erating in many developed countries. In addition, 
they calculated the percentage of the population 
that followed these recommendations, characterized 
their profile, and examined the risk of AMD.
The study included four thousand two hun-
dred and two participants in the Rotterdam 
study ≥ 55 years who were free from AMD at base-
line and followed for 9.1 ± 5.8 years. Dietary data 
were collected using a verified 170 food frequency 
questionnaire, and food consumption was divided 
into nutritional patterns based on Health Coun-
cil guidelines.
The results of the study were as follows — seven 
hundred and fifty-four people developed AMD. 
The consumption of the recommended amounts of 
vegetables (≥ 200 g/day), fruits (2 ×/day) and fish 
(2 ×/week) was 30.6%, 54.9% and 12.5% respec-
tively. In particular, fish consumption (2 ×/week) 
reduced the risk of AMD. Consumption of the rec-
ommended amounts of all 3 food groups was only 
3.7%, but following this pattern showed a further 
reduction in the risk of AMD.
To sum up, a diet of 200 g a day of vegetables, 
fruit twice a day and fish twice a week is associated 
with a significantly reduced risk of AMD [32].
A systematic literature review conducted by 
Chapman et al. identified eighteen high‐quality 
studies evaluating the role of diet and food intake 
in AMD. This work showed that the diet has a mul-
tifactorial effect on the occurrence and progression 
of AMD. The authors of the review recommend ad-
hering to the Mediterranean diet, which is based on 
a high intake of fruits, vegetables, legumes, whole 
grains and nuts; moderate consumption of fish, 
poultry and dairy products, the use of olive oil in-
stead of fats, small amounts of red wine and limited 
consumption of red meat. As for other diets, the 
Oriental diet pattern with higher intake of vegeta-
bles, legumes, fruits, whole grains, tomatoes and 
seafood is considered more favorable compared to 
the Western diet pattern, which is characterized by 
higher consumption of red meat, processed meat, 
and high-fat products dairy fried potatoes, refined 
beans and eggs. In addition, it was noted that high 
consumption of vegetables rich in carotenoids and 
fatty fish containing omega-3 fatty acids were ben-
eficial for those at risk of AMD. However, in order 
to reduce the risk of AMD progression, a minimum 
intake of vegetable oils and animal fats containing 
omega-6 fatty acids and red or processed meat is rec-
ommended. In addition, foods with a low glycemic 
index (IG) are preferred to foods with a high IG, 
and alcohol consumption should be limited.
ConClusion
The treatment of the dry form of age-related 
macular degeneration has been a big challenge for 
scientists for many years. To date, despite numer-
ous scientific studies including clinical trials, no 
causative treatment of this disease is known. Among 
the modifiable factors affecting the incidence and 
progression of AMD, it has been shown that sup-
plementation and, above all, a proper diet are very 
important. The currently recommended dietary 
supplementation in AMD patients has been de-
veloped based on the AREDS and AREDS2 stud-
ies (Tab. 2). This formula includes the intake of 
500 mg vitamin C, 400 IU. vitamin E, 25 mg zinc, 
2 mg copper, 10 mg lutein and 2 mg zeaxanthin 
per day. A special role is assigned to xanthophyll 
carotenoids-lutein and zeaxanthin, which are the 
main components of the macular pigment. They 
are thought to play an important role in main-
taining the morphological and functional integrity 
of the retina. Concentrated in the macula, these 
substances have the ability to filter blue light and 
table 2. recommended composition of dietary 
supplements for patients with age-related macular 
degeneration (amd) and their sources in nutritional 
products
nutrient food source
Carotenoids
Kale, spinach, watercress, basil, peas, 
lettuce, zucchini, broccoli, tomatoes, 
corn, Brussels sprouts, spring onions, 
egg yolk, pumpkin and leeks
Omega-3 fatty acids
Salmon, anchovy mackerel, tuna, 
sardines, and swordfish
Vitamin C
Fresh vegetables and fruits, especially 
brassicas, berries
Vitamin E
Olive oil, hazelnut oil, sunflower, 
almond, grape seed, almond, nuts, leafy 
vegetables, cereal grains
Zinc
Mussels, oysters, pork liver, almonds, 
beans, wholemeal flour
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deactivate reactive oxygen species, thus protecting 
against light-induced oxidative damage that is in-
volved in AMD pathogenesis. Studies have shown 
that consumption of lutein and zeaxanthin is as-
sociated with a lower risk of AMD progression, but 
remaining inconsistent about preventive effects of 
supplementation on AMD.
As mentioned earlier, diet has a vital role in 
AMD, so the provision of appropriate nutritional 
advice to those at risk of AMD is recommended. 
Current evidence suggests that improving diet qual-
ity, increasing the intake of foods containing the 
nutrients required by the retina, and avoiding foods 
that cause oxidative damage will play an impor-
tant role in protecting against AMD. With the ap-
proaching increase in the number of AMD patients 
in the aging population, healthcare professionals 
should actively promote food choices that minimize 
AMD risk.
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